Determination of valproic acid in human serum and pharmaceutical preparations by headspace liquid-phase microextraction gas chromatography-flame ionization detection without prior derivatization.
An efficient and fast extraction technique for the enrichment of valproic acid from human blood serum samples using the headspace liquid phase microextraction (HS-LPME) combined with gas chromatography (GC) analysis has been developed. The extraction was conducted by suspending a 2 microL drop of organic solvent in a 1 mL serum sample; following 20 min of extraction, withdrawing organic solvent into a syringe and injection into a GC with a flame ionization detector (FID), without any further pre-treatment. Four organic solvents, 1-decanole, benzyl alcohol, 1-octanol and n-dodecane, were studied as extractants, and n-dodecane was found to be the most sensitive solvent for valproic acid. The results revealed that HS-LPME is suitable for the successful extraction of valproic acid from human blood serum samples. Parameters like extraction time, ionic strength, pH, organic solvent volume, and temperature of the sample were studied and optimized to obtain the best extraction results. An enrichment factor of 27-fold was achieved in 20 min. The procedure resulted in a relative standard deviation of <13.2% (n=7) and a linear calibration range from 2 to 20 microg mL(-1) (r>0.98), and the limit of detection was 0.8 microg mL(-1) in serum blank samples. Overall, LPME proved to be a fast, sensitive and simple tool for the preconcentration of valproic acid from real samples. The proposed method was also applied to the analysis of valproate in pharmaceutical preparations.
Shahdousti
Parvin
P
Department of Chemistry, Faculty of Science, Tarbiat Modarres University, P.O. Box 14115-175, Tehran, Iran.
Mohammadi
Abdorreza
A
Alizadeh
Naader
N
D000927:Anticonvulsants / Q000032:analysis* / Q000097:blood; D002849:Chromatography, Gas / Q000379:methods*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009994:Osmolar Concentration; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D012680:Sensitivity and Specificity; D012997:Solvents; D014635:Valproic Acid / Q000032:analysis* / Q000097:blood
D000927:Anticonvulsants; D004364:Pharmaceutical Preparations; D012997:Solvents; D014635:Valproic Acid